APUS Stock Analysis: Buy, Sell, or Hold?

APUS - Apimeds Pharmaceuticals US, Inc.

PHARMACEUTICAL PREPARATIONS
$1.88
0.13 (7.43%) ▲
5d: +15.34%
30d: +41.35%
90d: +14.63%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 18, 2026 18d

Get Alerted When APUS Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: APUS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: APUS is currently trading at $1.88, which is considered slightly high relative to its 30-day fair value range of $1.69 to $1.89.

Technical Outlook: Technically, APUS is in a downtrend. Immediate support is located at $1.60, while resistance sits at $2.10. The stock is showing strong short-term momentum, up 7.4% recently.

Market Sentiment: APUS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Historical Trading Range $1.69 - $1.89
Company Quality Score 59/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 82.4%

All Signals

  • BULLISH: Strong technical setup (75/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+7.4%)

Trading Range Analysis

30-Day Trading Range $1.69 - $1.89
Current vs Trading Range SLIGHTLY HIGH

Support & Resistance Levels

Support Level $1.60
Resistance Level $2.10
Current Trend Downtrend
Technical data as of Apr 2, 2026

Fundamental Context

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: April 29, 2026 5:54 AM ET
Data refreshes hourly during market hours. Next update: 6:54 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check

Top Rated Drug Manufacturers - Specialty & Generic Stocks

Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
NBIX
Neurocrine Biosciences I…
STRONG BUY
25 analysts
$186 60 HOLD
ZTS
Zoetis Inc
STRONG BUY
19 analysts
$150 59 HOLD
LNTH
Lantheus Holdings Inc
STRONG BUY
13 analysts
$94 58 HOLD
BCRX
BioCryst Pharmaceuticals…
STRONG BUY
12 analysts
$21 58 HOLD
AVDL
Avadel Pharmaceuticals P…
STRONG BUY
8 analysts
$21 62 BUY

More Analysis for APUS

APUS Technical Chart APUS Price Prediction APUS Earnings Date APUS Investment Advisor APUS Fair Price Analyzer APUS Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals